ELLEAD, a leading company in cosmetic human application testing and bio-research, recently announced the publication of a paper on its 3D hair follicle organoid growth testing service in the international academic journal Biomaterials Research. Through this, the company has secured the credibility of its innovative technology, and is gaining market attention by collaborating with various clients. This service is based on the latest technology that can rapidly analyze over 100 results for one substance intended to promote hair growth, providing experimental results within two weeks.
This testing service has become a core technology necessary for the development of new drugs and cosmetics related to hair growth. Based on high reliability and scientific precision, ELLEAD is establishing a unique position in the bio-research and industry.
Recently, this research achievement was published in Biomaterials Research, an international academic journal with an impact factor of 8.1, under the title “High-Throughput Screening of 3-Dimensional Co-culture Hair Follicle Mimetic Tissue with an Enhanced Extracellular Matrix for the Screening of Hair Growth-Promoting Compounds.” The impact factor is a measure of how often articles in a journal are cited, and a higher number indicates a greater influence of the journal. The publication in a highly reputable international journal is proof of the outstanding academic achievement.
The paper evaluated that the 3D co-culture system utilizing a special substrate reproduces ECM (extracellular matrix) conditions similar to those of a living body, and is a platform with high-speed screening capabilities, reproducibility, and ease of use. This platform is attracting attention as an important tool for the development of hair loss treatments and screening of drug candidates. Furthermore, this study demonstrates that cell-based tests using hair follicle organoids play an important role in understanding hair growth mechanisms and evaluating the efficacy of related substances.
The special substrate used in the test is being used in various fields such as promoting differentiation of liver progenitor cells, liver cell toxicity tests, non-alcoholic fatty liver disease drug screening, and promoting differentiation of osteoblasts and myoblasts, and has been published in numerous research papers.
ELLEAD is continuously strengthening its research and development capabilities and is striving to become a global leader in the bio and cosmetic industries. This achievement is evaluated as a case that further strengthens the trust of clients and increases the commercialization potential of 3D cell culture technology.
The ELLEAD research team said, “We are achieving positive results with a continuous increase in the number of orders,” and added, “We will continue to meet the expectations of our clients with innovative technology and precise testing in the future.”
Based on the success of this testing service, ELLEAD plans to strengthen its competitiveness in the global market and consolidate its leading position.
Advertorial
Byun Sanghyuk
https://www.skinobs.com/c/labo.php?id=72
Acheless is an essential wearable device for modern society, where digital living is commonplace. To…
Linking consumer data with sensory data is an essential step in formulating products that accurately…
Odournet France - Sensenet, experts in olfactory measurement and analysis, reached a crucial milestone in May 2024 with the relocation of its activities to modern, high-performance premises. This new environment reflects our determination to combine innovation,…